Joseph C Cleveland Jr
Overview
Explore the profile of Joseph C Cleveland Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
169
Citations
8109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Mehra M, Nayak A, Morris A, Lanfear D, Nemeh H, Desai S, et al.
JACC Heart Fail
. 2022 Dec;
10(12):948-959.
PMID: 36456068
Background: Clinical trials inform on average efficacy, but individualized risk assessments for outcome prediction are important in guiding treatment implementation. Objectives: The authors developed and validated a patient-specific risk score...
22.
Tsai C, Rodriguez M, Van Keuren A, Phillips C, Shushunov H, Lee J, et al.
Mol Cell
. 2022 Oct;
82(19):3661-3676.e8.
PMID: 36206740
Mitochondrial Ca uptake, mediated by the mitochondrial Ca uniporter, regulates oxidative phosphorylation, apoptosis, and intracellular Ca signaling. Previous studies suggest that non-neuronal uniporters are exclusively regulated by a MICU1-MICU2 heterodimer....
23.
Strobel R, Savage C, Horvath K, Nichols 3rd F, Savage E, Kasirajan V, et al.
Ann Thorac Surg
. 2022 Aug;
114(5):1542-1549.
PMID: 35963441
Reimbursement for cardiothoracic surgery continues to be threatened with enormous financial cuts ranging from 5% to 10% in recent years. In this policy perspective, we describe the history of reimbursement...
24.
25.
Vidula H, Takeda K, Estep J, Silvestry S, Milano C, Cleveland Jr J, et al.
JACC Heart Fail
. 2022 Jun;
10(7):470-481.
PMID: 35772857
Background: In the MOMENTUM 3 (Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3) pivotal trial, the HeartMate 3 (HM3) fully magnetically levitated left...
26.
John R, Kanwar M, Cleveland Jr J, Uriel N, Naka Y, Salerno C, et al.
J Thorac Cardiovasc Surg
. 2022 Jun;
166(6):1684-1694.e18.
PMID: 35643769
Background: Correction of valvular disease is often undertaken during left ventricular assist device (LVAD) implantation with uncertain benefit. We analyzed clinical outcomes with HeartMate 3 (HM3; Abbott) LVAD implantation in...
27.
Hoffman J, Higa K, Lin Y, Reece T, Cleveland Jr J, Aftab M, et al.
Semin Cardiothorac Vasc Anesth
. 2022 May;
26(2):154-161.
PMID: 35591803
Cardiac surgery continues to evolve. The last year has been notable for many reasons. The guidelines for coronary revascularization introduced significant discord. The pandemic continues to affect the care on...
28.
Rove J, Cleveland Jr J
J Thorac Cardiovasc Surg
. 2022 May;
167(2):656-657.
PMID: 35504765
No abstract available.
29.
Kanwar M, Pagani F, Mehra M, Estep J, Pinney S, Silvestry S, et al.
J Card Fail
. 2022 May;
28(7):1158-1168.
PMID: 35504508
Background: As left ventricular assist device (LVAD) survival rates continue to improve, evaluating site-specific variability in outcomes can facilitate identifying targets for quality-improvement initiative opportunities in the field. Methods: Deidentified...
30.
Molina E, Cowger J, Lee S, Horstmanshof D, Cleveland Jr J, Goldstein D, et al.
Ann Thorac Surg
. 2022 Apr;
114(6):2262-2269.
PMID: 35452663
Background: Outcomes in patients with smaller body size after HeartMate 3 left ventricular assist device (HM3) implantation are not well characterized. We sought to evaluate outcomes in smaller vs larger...